RecruitingNot ApplicableNCT06359418

Acupuncture for Prediabetes With Combined Obesity

Acupuncture for Prediabetes With Combined Obesity: a Multicenter Randomized Controlled Trial

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Enrollment

260 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Obesity Prediabetes Abdominal Obesity

Summary

The clinical trial aims to evaluate the efficacy and safety of acupuncture in reducing weight and waist circumference while modulating glucose and lipid metabolism in Prediabetes with Combined Obesity.

Eligibility

Min Age: 18 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Acupuncture and a medical device called Sham acupuncture for people with abdominal obesity, obesity, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAcupuncture

The acupuncture needle (size 0.30x40mm) will be inserted into DU20, EX-HN3 and GB8 acupoints at the depth of 15-30mm; The acupuncture needle (size 0.30x50mm or size 0.30x75mm) will be inserted into other acupoints at the depth of 40-70mm; Manipulation will be done after insertion (6 times of small amplitude and uniform twist).

DEVICESham acupuncture

The acupuncture needle (size 0.20x25mm) will be inserted into all acupoints at the depth of 2mm without any manipulation.